Outpatient Drug Clinic (CAS) Vall Hebron, Psychiatry Department, Vall Hebron Hospital-ASPB, Universidad Autónoma de Barcelona, CIBERSAM, Spain; Department of Psychiatry and Legal Medicine, Universidad Autónoma de Barcelona, Spain; Department of Psychiatry, Hospital Universitari Vall d׳Hebron, CIBERSAM, Universitad Autònoma de Barcelona, Spain.
Outpatient Drug Clinic (CAS) Vall Hebron, Psychiatry Department, Vall Hebron Hospital-ASPB, Universidad Autónoma de Barcelona, CIBERSAM, Spain.
Psychiatry Res. 2014 May 30;216(3):398-403. doi: 10.1016/j.psychres.2014.01.026. Epub 2014 Jan 28.
The aim of this study is to compare the clinical characteristics of three groups of patients in treatment for cocaine dependence: patients without any psychotic symptoms (NS), patients with transient psychotic symptoms (PS) and patients with cocaine-induced psychotic disorder (CIPD). An observational and retrospective study of 150 cocaine-dependent patients undergoing treatment in the Drug Unit of the Psychiatry Department of University Hospital Vall d׳Hebron in Barcelona (Spain) using these three groups, NS, PS and CIPD, was performed. All patients were evaluated with the PRISM interview. ANOVA, χ2 tests and multivariate multinomial regression analysis were used to perform statistical analyses. Seven patients with a primary psychotic disorder were discharged. Forty-six patients (32.1%) did not report any psychotic symptoms. Ninety-seven patients (67.9%) presented with a history of any cocaine-induced psychotic symptom and were considered as the cocaine-induced psychotic (CIP) group. Among them, 39 (27.3%) were included in the PS group and 58 (40.6%) were included in the CIPD group. A history of imprisonment was found significantly more frequently in the PS group than in the NS group. The distribution of age at onset of dependence, lifetime cannabis abuse or dependence and imprisonment were significantly different between the NS and CIPD groups. We conclude that in cocaine-dependent patients, clinicians should be advised about the risk of development of psychotic symptoms. The presence of some psychotic symptoms could increase the potential risks of disturbing behaviours.
无任何精神病症状的患者(NS)、有短暂精神病症状的患者(PS)和可卡因引起的精神病障碍患者(CIPD)。对在巴塞罗那 Vall d'Hebron 大学医院精神病学部药物科接受治疗的 150 名可卡因依赖患者进行了一项观察性、回顾性研究,使用了这三组患者,即 NS、PS 和 CIPD。所有患者均接受 PRISM 访谈评估。采用 ANOVA、χ2 检验和多变量多项回归分析进行统计分析。7 名原发性精神病患者出院。46 名患者(32.1%)未报告任何精神病症状。97 名患者(67.9%)有可卡因引起的精神病症状史,被认为是可卡因引起的精神病(CIP)组。其中,39 名患者(27.3%)被纳入 PS 组,58 名患者(40.6%)被纳入 CIPD 组。PS 组的监禁史明显多于 NS 组。NS 和 CIPD 组在依赖开始年龄、终生大麻滥用或依赖和监禁的分布上存在显著差异。我们得出结论,在可卡因依赖患者中,临床医生应被告知出现精神病症状的风险。存在一些精神病症状可能会增加扰乱行为的潜在风险。